Target intelligence / Profile preview

AMMECR1 intronic transcript 1 (AMMECR1-IT1)

Target
AMMECR1-IT1
Molecular classification
Other, non-coding RNA transcript, lncRNA
01

Overview

AMMECR1 intronic transcript 1 (AMMECR1-IT1) is a long non-coding RNA transcribed from an intronic region of the AMMECR1 gene on the X chromosome. Its specific biological functions have not been definitively established. Intronic transcripts such as AMMECR1-IT1 may regulate gene expression by influencing mRNA cleavage, polyadenylation, or splicing dynamics, and may help fine-tune cellular differentiation and identity in stem cells[3]. However, AMMECR1-IT1 itself is not recognized as a protein, receptor, enzyme, transporter, or other established therapeutic target in the current literature or drug development databases[1][3]. The protein-coding gene AMMECR1, from which this transcript originates, is associated with cell proliferation and developmental disorders, but this is distinct from the transcript itself[4][5]. Key clarification: AMMECR1-IT1 should not be confused with the AMMECR1 protein or gene, which is sometimes implicated in disease[1][4][5]. There is no evidence that AMMECR1-IT1 is a direct target for therapeutic intervention, nor are there known drugs that interact with this RNA transcript[1]. If you require information on the protein-coding gene AMMECR1 (AMMECR nuclear protein 1), let me know—this is a separate entity with established biological and disease roles[4][5][6][7].

Other names
AMMECR1 intronic transcript 1
02

Mechanism of action

Not applicable (lncRNAs are generally not targeted by drugs; no drugs or mechanism of action described)

03

Biological functions

Regulation of mRNA processing and splicing
04

Disease associations

Other

Beyond the preview

Go deeper on AMMECR1 intronic transcript 1 (AMMECR1-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMMECR1 intronic transcript 1 (AMMECR1-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call